Consun Pharmaceutical Group (HKSE:01681) Margin of Safety % (DCF FCF Based) : 78.69% (As of May. 17, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-05-17), Consun Pharmaceutical Group's Predictability Rank is 3.5-Stars. Consun Pharmaceutical Group's intrinsic value calculated from the Discounted FCF model is HK$23.19 and current share price is HK$6.98. Consequently,

Consun Pharmaceutical Group's Margin of Safety % (DCF FCF Based) using Discounted FCF model is 78.69%.

Competitive Comparison of Consun Pharmaceutical Group's Margin of Safety % (DCF FCF Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Consun Pharmaceutical Group's Margin of Safety % (DCF FCF Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's Margin of Safety % (DCF FCF Based) falls into.

Consun Pharmaceutical Group Margin of Safety % (DCF FCF Based) Calculation

Consun Pharmaceutical Group's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)	=	(Intrinsic Value: DCF (FCF Based)	-	Current Price)	/	Intrinsic Value: DCF (FCF Based)
	=	(32.75	-	6.98)	/	32.75
	=	78.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Consun Pharmaceutical Group Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Consun Pharmaceutical Group (HKSE:01681) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Margin of Safety % (DCF FCF Based)

Traded in Other Exchanges

C1P:Germany

Address

71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN

Website

https://www.chinaconsun.com

Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Consun Pharmaceutical Group (HKSE:01681) Headlines

No Headlines